6962-62-5 Usage
Uses
Used in Pharmaceutical Industry:
(2E)-3-(1,3-benzodioxol-5-yl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one is used as a pharmaceutical agent for its potential antioxidant, anti-inflammatory, and anticancer properties. Its bioactivity and chemical structure make it a promising candidate for the development of natural medicine and pharmaceutical research.
Used in Nutraceutical Industry:
(2E)-3-(1,3-benzodioxol-5-yl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one is used as a nutraceutical ingredient for its health-promoting properties. Its antioxidant and anti-inflammatory effects can contribute to the development of dietary supplements and functional foods that promote overall health and well-being.
Used in Cosmetic Industry:
(2E)-3-(1,3-benzodioxol-5-yl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one is used as an active ingredient in cosmetic products for its potential skin health benefits. Its antioxidant properties can help protect the skin from environmental stressors and support skin health and appearance.
Used in Agricultural Industry:
(2E)-3-(1,3-benzodioxol-5-yl)-1-(2,4-dihydroxyphenyl)prop-2-en-1-one can be used as a natural pesticide or growth promoter in agriculture. Its bioactive properties may help protect plants from pests and diseases, promoting healthy growth and crop yield.
Check Digit Verification of cas no
The CAS Registry Mumber 6962-62-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,6 and 2 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 6962-62:
(6*6)+(5*9)+(4*6)+(3*2)+(2*6)+(1*2)=125
125 % 10 = 5
So 6962-62-5 is a valid CAS Registry Number.
6962-62-5Relevant academic research and scientific papers
Synthesis of butein analogues and their anti-proliferative activity against gefitinib-resistant non-small cell lung cancer (NSCLC) through Hsp90 inhibition
Seo, Young Ho,Jeong, Ju Hui
, p. 1294 - 1298 (2014/06/09)
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer representing 85% of lung cancer patients. Despite several EGFR-targeted drugs have been developed in the treatment of NSCLC, the clinical efficacy of these EGFR-targeted therapies i
Synthesis and evaluation of antiinflammatory activity of substituted chalcone derivatives
Zhang, Xue-Wu,Zhao, Dong-Hai,Quan, Ying-Chun,Sun, Liang-Peng,Yin, Xiu-Mei,Guan, Li-Ping
experimental part, p. 403 - 412 (2011/02/27)
In an effort to develop potent antiinflammatory agents, a series of substituted chalcone derivatives was synthesized and evaluated for antiinflammatory activity through monitoring of their ability to inhibit xylene-induced ear edema in mice. Some of the tested compounds exhibited significant activity, and compounds 3f [(E)-1-(2,4-dihydroxyphenyl)-3-(4- dimethylamino)phenyl)prop-2-en-1-one] and 3h [(E)-3-(4-chlorophenyl)-1-(2,4- dihydroxyphenyl)prop-2-en-1-one] showed the highest antiinflammatory activity (62 and 68% inhibition, respectively, 2 h before administration), comparable with or even slightly more potent than the reference drug ibuprofen (53%). Furthermore, the structure-activity relationship of these substituted chalcone derivatives was demonstrated.
